Medical and agricultural uses of beta-carbolines as inhibitors of fungal DYRK-family kinases
WO2026112718A1PCT designated stage Publication Date: 2026-06-04THE GOVERNING COUNCIL OF THE UNIV OF TORONTO
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- THE GOVERNING COUNCIL OF THE UNIV OF TORONTO
- Filing Date
- 2024-11-28
- Publication Date
- 2026-06-04
Smart Images

Figure CA2024051590_04062026_PF_FP_ABST
Abstract
Methods and compositions for treating, preventing and controlling fungal infections, including superficial infections, using compounds of the β-carboline class are disclosed. Pharmaceutical compositions comprising β-carbolines alone, or in combination with therapeutically effective amounts of an antimycotic, are administered to a subject to treat or prevent a superficial fungus infection such as those caused by fungi selected from the Candida or Trichophyton genus, infections such as dermatomycosis, diaper rash (yeast dermatitis), athletes' foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea capitis) and cutaneous candidiasis. Methods of treating, preventing or controlling fungal infections in a plant are also disclosed, wherein a composition comprising an agriculturally acceptable amount of a β-carboline and a fungicide is administered to the plant and / or the locus of the plant, β-carbolines having the following formula are preferred. (Formula I).
Need to check novelty before this filing date? Find Prior Art